1. SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1. Issue 40 (24th September 2021) Authors: Law, John Lok Man; Logan, Michael; Joyce, Michael A.; Landi, Abdolamir; Hockman, Darren; Crawford, Kevin; Johnson, Janelle; LaChance, Gerald; Saffran, Holly A.; Shields, Justin; Hobart, Eve; Brassard, Raelynn; Arutyunova, Elena; Pabbaraju, Kanti; Croxen, Matthew; Tipples, Graham; Lemieux, M. Joan... Journal: Vaccine Issue: Volume 39:Issue 40(2021) Page Start: 5769 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗